Celtic, which sells health insurance plans called Ambetter on the Affordable Care Act exchange, allegedly limited the amount of anti-anxiety, antipsychotic, smoking cessation, schizophrenia, addiction treatment and HIV/AIDS medications it would cover, according to the report.
Illinois also alleged that Celtic violated the Network Adequacy and Transparency Act by not providing members with an up-to-date, accurate directory of its in-network providers, according to the report.
Centene did not immediately respond to the Tribune’s request for comment, according to the report.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
